BMP2, 5 and rhBMP9 has been reported to be involved in RAS-MAPK mediated pathway that activates p65 cytokine and during tumorigenesis and thus proliferate ovarian cancer [63,64]. This evidence concerns the gene BMP2 and ovarian cancer.